Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma

References

• Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689–697.
   PubMed Web of Science ®Google Scholar
• Lee BW, Schwartz RA, Janniger CK. Melasma. G Ital Dermatol Venereol. 2017;152(1):36–45.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gover MD, Nouri K, et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048–1065.
   PubMed Web of Science ®Google Scholar
• Landau M. Chemical peels. Clin Dermatol. 2008;26(2):200–208.
   PubMed Web of Science ®Google Scholar
• Polnikorn N. Treatment of refractory dermal melasma with the Medlite C6 Q-switched Nd:YAG laser: two case reports. J Cosmet Laser Ther. 2008;10(3):167–173.
   PubMed Web of Science ®Google Scholar
• Jutley GS, Rajaratnam R, Halpern J, et al. Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review. J Am Acad Dermatol. 2014;70(2):369–373.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Moon SH, Cho SH, et al. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venerol. 2017; 97(7):776–781.
   PubMed Web of Science ®Google Scholar
• Chung JY, Lee JH, Lee JH. Topical tranexamic acid as an adjuvant treatment in melasma: side-by- side comparison clinical study. J Dermatolog Treat. 2015;4:1–18.
   Google Scholar
• Emer J. Platelet-rich plasma (PRP): current applications in dermatology. Skin Therapy Lett. 2019;24(5):1–6.
   PubMedGoogle Scholar
• Peng GL. Platelet-rich plasma for skin rejuvenation: facts, fiction, and pearls for practice. Facial Plast Surg Clin North Am. 2019;27(3):405–411.
   PubMed Web of Science ®Google Scholar
• Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Womens Dermatol. 2017;3(1):11–20.
   PubMedGoogle Scholar
• Arellano I, Cestari T, Ocampo-Candiani J, et al. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity. J Eur Acad Dermatol Venereol. 2012;26(5):611–618.
   PubMed Web of Science ®Google Scholar
• Patil SS, Deshmukh AR. Comparative study of efficacy of intradermal tranexamic acid versus topical tranexamic acid versus triple combination in melasma. Pigment Int. 2019;6(2):84.
   Google Scholar
• Manosroi A, Podjanasoonthon K, Manosroi J. Development of novel topical tranexamic acid liposome formulations. Int J Pharm. 2002;235(1-2):61–70.
   PubMed Web of Science ®Google Scholar
• Lacz NL, Vafaie J, Kihiczak NI, et al. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004; 43(5):362–365.
   PubMed Web of Science ®Google Scholar
• Steiner D, Feola C, Bialeski N, et al. Study evaluating the efficacy of topical and injected tranexamic acid in treatment of melasma. Surg Cosmet Dermatol. 2009;1:174–177.
   Google Scholar
• Perper M, Eber AE, Fayne R, et al. Tranexamic acid in the treatment of melasma: a review of the literature. Am J Clin Dermatol. 2017;18(3):373–381.
   PubMed Web of Science ®Google Scholar
• Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci. 2014;19:753–757.
   PubMed Web of Science ®Google Scholar
• Banihashemi M, Zabolinejad N, Jaafari MR, et al. Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol. 2015;14(3):174–177.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Park JY, Shibata T, et al. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol. 2016;41(5):480–485.
   PubMed Web of Science ®Google Scholar
• Taraz M, Niknam S, Ehsani AH. Tranexamic acid in treatment of melasma: a comprehensive review of clinical studies. Dermatol Ther. 2017;30(3).
   PubMed Web of Science ®Google Scholar
• Kanechorn N, Ayuthaya P, Niumphradit N, et al. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012;14(3):150–154.
   PubMed Web of Science ®Google Scholar
• Tse TW, Hui E. Tranexamic acid: an important adjuvant in the treatment of melasma. J Cosmet Dermatol. 2013;12(1):57–66.
   PubMed Web of Science ®Google Scholar
• Ng SP, Marcant M, Davis AF. In vitro human skin concentrations following topical application of 2% tranexamic acid in co-enhancer cream and branded cream formulations. J Cosmet Dermatol. 2020 ;Jan 21. [Epub ahead of print]
   Web of Science ®Google Scholar
• Merchán WH, Gómez LA, Chasoy ME, et al. Platelet-rich plasma, a powerful tool in dermatology. J Tissue Eng Regen Med. 2019;13(5):892–901.
   PubMed Web of Science ®Google Scholar
• Sirithanabadeekul P, Dannarongchai A, Suwanchinda A. Platelet-rich plasma treatment for melasma: a pilot study. J Cosmet Dermatol. 2020;19(6):1321–1327. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Cayırlı M, Calışkan E, Açıkgöz G, et al. Regression of melasma with platelet-rich plasma treatment. Ann Dermatol. 2014; 26(3):401–402.
   PubMed Web of Science ®Google Scholar
• Pathania V, Oberoi B, Shankar P, et al. Single-handed vampire facial: combining microneedling with platelet-rich plasma for single-hand use. J Am Acad Dermatol. 2019 Aug 10;S0190–9622(19)32560–5. [Epub ahead of print].
   Web of Science ®Google Scholar
• Hofny ERM, Abdel-Motaleb AA, Ghazally A, et al. Platelet-rich plasma is a useful therapeutic option in melasma. J Dermatolog Treat. 2019;30(4):396–401.
   PubMed Web of Science ®Google Scholar
• Tawfic SO, Abdel Halim DM, Albarbary A, et al. Assessment of combined fractional CO2 and tranexamic acid in melasma treatment. Lasers Surg Med. 2019;51(1):27–33.
   PubMed Web of Science ®Google Scholar
• Laothaworn V, Juntongjin P. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. J Cosmet Laser Ther. 2018;20(6):320–325.
   PubMed Web of Science ®Google Scholar
• Malik F, Hanif MM, Mustafa G. Combination of oral tranexamic acid with topical 3% tranexamic acid versus oral tranexamic acid with topical 20% azelaic acid in the treatment of melasma. J Coll Physicians Surg Pak. 2019;29(6):502–504.
   PubMed Web of Science ®Google Scholar
• Zhang L, Tan WQ, Fang QQ, et al. Tranexamic acid for adults with melasma: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:1683414.
   PubMed Web of Science ®Google Scholar
• Sharma R, Mahajan VK, Mehta KS, et al. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol. 2017;42(7):728–734.
   PubMed Web of Science ®Google Scholar
• Na JI, Choi SY, Yang SH, et al. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2013;27(8):1035–1039.
   PubMed Web of Science ®Google Scholar